CA Patent

CA2721072A1 — Anticancer methods employing extracts of gleditsia sinensis lam

Assigned to Bionovo Inc · Expires 2009-10-15 · 17y expired

What this patent protects

Selective apoptotic extracts of Gleditsia sinensis Lam are provided. Also provided are methods of using said extracts to in-duce apoptosis in specific cells, especially in a human. Provided as well are uses of the extracts of Gleditsia sinensis Lam for the preparation of a medica…

USPTO Abstract

Selective apoptotic extracts of Gleditsia sinensis Lam are provided. Also provided are methods of using said extracts to in-duce apoptosis in specific cells, especially in a human. Provided as well are uses of the extracts of Gleditsia sinensis Lam for the preparation of a medicament for the selective induction of apoptosis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2721072A1
Jurisdiction
CA
Classification
—
Expires
2009-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Bionovo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.